B7-2 regulates survival, phenotype, and function of APCs

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6236-6241

  Yadav, Deepak ^a   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD86 ANTIGEN; CD8ALPHA ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; FEMALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

EID: 34248222660     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6236     Document Type: Article

References (43)

1. Tan, J. K., and H. C. O'Neill. 2005. Maturation requirements for dendritic cells in T cell stimulation leading to tolerance versus immunity. J. Leukocyte Biol. 78: 319-324.
2. Hugues, S., A. Boissonnas, S. Amigorena, and L. Fetler. 2006. The dynamics of dendritic cell-T cell interactions in priming and tolerance. Curr. Opin. Immunol. 18: 491-495.
3. Grohmann, U., C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M. L. Belladonna, R. Bianchi, M. C. Fioretti, and P. Puccetti. 2002. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3: 1097-1101.
4. Orabona, C., U. Grohmann, M. L. Belladonna, F. Fallarino, C. Vacca, R. Bianchi, S. Bozza, C. Volpi, B. L. Salomon, M. C. Fioretti, et al. 2004. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat. Immunol. 5: 1134-1142.
5. Zhang, X., J. C. Schwartz, S. C. Almo, and S. G. Nathenson. 2003. Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling. Proc. Natl. Acad. Sci. USA 100: 2586-2591.
6. Hathcock, K. S., and R. J. Hodes. 1996. Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses. Adv. Immunol. 62: 131-166.
7. Kin, N. W., and V. M. Sanders. 2006. CD86 stimulation on a B cell activates the phosphatidylinositol 3-kinase/Akt and phospholipase Cγ2/protein kinase Cαβ signaling pathways. J. Immunol. 176: 6727-6735.
8. Schuurhuis, D. H., N. Fu, F. Ossendorp, and C. J. Melief. 2006. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140: 53-72.
9. Kato, M., T. K. Neil, D. B. Fearnley, A. D. McLellan, S. Vuckovic, and D. N. Hart. 2000. Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int. Immunol. 12: 1511-1519.
10. Bonifaz, L. C., D. P. Bonnyay, A. Charalambous, D. I. Darguste, S. Fujii, H. Soares, M. K. Brimnes, B. Moltedo, T. M. Moran, and R. M. Steinman. 2004. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199: 815-824.
11. - dendritic cell subset by a maturation process involving CD8α, DEC-205, and CD24 up-regulation. Blood 99: 999-1004.
12. + dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302.
13. Belz, G. T., W. R. Heath, and F. R. Carbone. 2002. The role of dendritic cell subsets in selection between tolerance and immunity. Immunol. Cell Biol. 80: 463-468.
14. Okazaki, T., and T. Honjo. 2006. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol. 27: 195-201.
15. Rescigno, M., M. Martino, C. L. Sutherland, M. R. Gold, and P. Ricciardi-Castagnoli. 1998. Dendritic cell survival and maturation are regulated by different signaling pathways. J. Exp. Med. 188: 2175-2180.
16. + T cells. J. Exp. Med. 185: 2133-2141.
17. Wang, J., L. Zheng, A. Lobito, F. K. Chan, J. Dale, M. Sneller, X. Yao, J. M. Puck, S. E. Straus, and M. J. Lenardo. 1999. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98: 47-58.
18. Yadav, D., V. Judkowski, M. Flodstrom-Tullberg, L. Sterling, W. L. Redmond, L. Sherman, and N. Sarvetnick. 2004. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets. J. Immunol. 173: 3631-3639.
19. Salomon, B., L. Rhee, H. Bour-Jordan, H. Hsin, A. Montag, B. Soliven, J. Arcella, A. M. Girvin, J. Padilla, S. D. Miller, and J. A. Bluestone. 2001. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J. Exp. Med. 194: 677-684.
20. Geijtenbeek, T. B., P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram-Panday, G. C. van Duijnhoven, G. Kraal, A. J. van Oosterhout, and Y. van Kooyk. 2002. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 100: 2908-2916.
21. Velupillai, P., J. P. Carroll, and T. L. Benjamin. 2002. Susceptibility to polyomavirus-induced tumors in inbred mice: role of innate immune responses. J. Virol. 76: 9657-9663.
22. Nolte, M. A., R. Arens, M. Kraus, M. H. van Oers, G. Kraal, R. A. van Lier, and R. E. Mebius. 2004. B cells are crucial for both development and maintenance of the splenic marginal zone. J. Immunol. 172: 3620-3627.
23. Hackstein, H., T. Taner, A. J. Logar, and A. W. Thomson. 2002. Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. Blood 100: 1084-1087.
24. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
25. Becker, M. D., S. R. Planck, S. Crespo, K. Garman, R. J. Fleischman, P. Dullforce, G. W. Seitz, T. M. Martin, D. C. Parker, and J. T. Rosenbaum. 2003. Immunohistology of antigen-presenting cells in vivo: a novel method for serial observation of fluorescently labeled cells. Invest. Ophthalmol. Vis. Sci. 44: 2004-2009.
26. O'Keeffe, M., H. Hochrein, D. Vremec, J. Pooley, R. Evans, S. Woulfe, and K. Shortman. 2002. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99: 2122-2130.
27. Larsen, E. C., T. Ueyama, P. M. Brannock, Y. Shirai, N. Saito, C. Larsson, D. Loegering, P. B. Weber, and M. R. Lennartz. 2002. A role for PKC-ε in FcγR-mediated phagocytosis by RAW 264.7 cells. J. Cell Biol. 159: 939-944.
28. Larsen, E. C., J. A. DiGennaro, N. Saito, S. Mehta, D. J. Loegering, J. E. Mazurkiewicz, and M. R. Lennartz. 2000. Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells. J. Immunol. 165: 2809-2817.
29. Newton, A. C. 1997. Regulation of protein kinase C. Curr. Opin. Cell Biol. 9: 161-167.
30. Sallusto, F., M. Cella, C. Danieli, and A. Lanzavecchia. 1995. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182: 389-400.
31. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170: 4437-4440.
32. - murine dendritic cell subsets. J. Immunol. 172: 4826-4833.
33. - subclasses of dendritic cells direct the development of distinct T helper cells in vivo. J. Exp. Med. 189: 587-592.
34. Tsujimura, H., T. Tamura, C. Gongora, J. Aliberti, C. Reis e Sousa, A. Sher, and K. Ozato. 2003. ICSBP/IRF-8 retrovirus transduction rescues dendritic cell development in vitro. Blood 101: 961-969.
35. Kriehuber, E., W. Bauer, A. S. Charbonnier, D. Winter, S. Amatschek, D. Tamandl, N. Schweifer, G. Stingl, and D. Maurer. 2005. Balance between NF-κB and JNK/AP-1 activity controls dendritic cell life and death. Blood 106: 175-183.
36. Chen, M., Y. H. Wang, Y. Wang, L. Huang, H. Sandoval, Y. J. Liu, and J. Wang. 2006. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311: 1160-1164.
37. Wilson, N. S., and J. A. Villadangos. 2005. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 86: 241-305.
38. Menges, M., S. Rossner, C. Voigtlander, H. Schindler, N. A. Kukutsch, C. Bogdan, K. Erb, G. Schuler, and M. B. Lutz. 2002. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195: 15-21.
39. Thibeault, A., H. Zekki, W. Mourad, D. Charron, and R. Al-Daccak. 1999. Triggering HLA-DR molecules on human peripheral monocytes induces their death. Cell. Immunol. 192: 79-85.
40. McLellan, A., M. Heldmann, G. Terbeck, F. Weih, C. Linden, E. B. Brocker, M. Leverkus, and E. Kampgen. 2000. MHC class II and CD40 play opposing roles in dendritic cell survival. Eur. J. Immunol. 30: 2612-2619.
41. Castrillo, A., D. J. Pennington, F. Otto, P. J. Parker, M. J. Owen, and L. Bosca. 2001. Protein kinase Cε is required for macrophage activation and defense against bacterial infection. J. Exp. Med. 194: 1231-1242.
42. Cheeseman, K. L., T. Ueyama, T. M. Michaud, K. Kashiwagi, D. Wang, L. A. Flax, Y. Shirai, D. J. Loegering, N. Saito, and M. R. Lennartz. 2006. Targeting of protein kinase C-ε during Fcγ receptor-dependent phagocytosis requires the εC1B domain and phospholipase C-γ1. Mol. Biol. Cell. 17: 799-813.
43. Ueyama, T., M. R. Lennartz, Y. Noda, T. Kobayashi, Y. Shirai, K. Rikitake, T. Yamasaki, S. Hayashi, N. Sakai, H. Seguchi, et al. 2004. Superoxide production at phagosomal cup/phagdsome through β1 protein kinase C during FcγR-mediated phagocytosis in microglia. J. Immunol. 173: 4582-4589.